Aevi Genomic Medicine, Inc.
(NASDAQ : GNMX)

( )
GNMX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.95%69.150.0%$1917.83m
NVAXNovavax, Inc. 9.93%146.5196.5%$1301.01m
SRNESorrento Therapeutics, Inc. -4.38%12.441.5%$767.50m
GILDGilead Sciences, Inc. 0.47%68.501.0%$580.36m
AMGNAmgen, Inc. 0.36%239.711.3%$465.88m
REGNRegeneron Pharmaceuticals, Inc. 0.28%612.572.7%$378.37m
VRTXVertex Pharmaceuticals, Inc. 0.05%267.291.9%$351.81m
BIIBBiogen, Inc. 0.32%289.451.4%$344.47m
ILMNIllumina, Inc. -1.69%347.563.5%$340.75m
BNTXBioNTech SE -3.32%68.640.0%$334.95m
ATNMActinium Pharmaceuticals, Inc. -1.21%9.7913.3%$231.53m
EBSEmergent BioSolutions, Inc. -1.09%133.476.4%$198.26m
VXRTVaxart, Inc. 0.55%9.140.0%$194.27m
MCRBSeres Therapeutics, Inc. -4.62%27.263.6%$181.12m
ALXNAlexion Pharmaceuticals, Inc. 1.06%102.971.9%$162.43m

Company Profile

Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.